Back to Search
RAJEE JOYCE, MD
MD
Pediatrics Physician
NPI: 1427039882Individual
Specialties, Licenses & Credentials
Research & Publications (20)
A phase I-II study of rituximab, ifosfamide, mitoxantrone and etoposide (R-IME) for B cell non-Hodgkin's lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT).
PMID 12736227·Ann Oncol·2003
3-trial
Rituximab and ifosfamide, mitoxantrone, etoposide (RIME) with Neupogen support for B-cell non-Hodgkin's lymphoma prior to high-dose chemotherapy with autologous haematopoietic transplant.
PMID 11486404·Eur J Haematol Suppl·2001
3-trial
Reported care quality in federal Ryan White HIV/AIDS Program supported networks of HIV/AIDS care.
PMID 19484615·AIDS Care·2009
4-observational
A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas.
PMID 19344412·Br J Haematol·2009
3-trial
Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: implications for posttransplant survival.
PMID 18261838·Exp Hematol·2008
8-other
A case of HIV-negative primary effusion lymphoma treated with bortezomib, pegylated liposomal doxorubicin, and rituximab.
PMID 18854285·Clin Lymphoma Myeloma·2008
5-case
Staphylococcus aureus HrtA is an ATPase required for protection against heme toxicity and prevention of a transcriptional heme stress response.
PMID 18326576·J Bacteriol·2008
8-other
Chemical and archaeological evidence for the earliest cacao beverages.
PMID 18024588·Proc Natl Acad Sci U S A·2007
8-other
Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248.
PMID 17545538·Clin Cancer Res·2007
3-trial
False-positive axillary lymph node on FDG-PET/CT scan resulting from immunization.
PMID 17053400·Clin Nucl Med·2006
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 40 HOLLAND ST
SOMERVILLE, MA 02144 - Phone
- (617) 629-6300
Quick Facts
- NPI
- 1427039882
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile